Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 RSLBF | Healthcare | $20.00 | 0.00 | $598.88M | 29.78 | 1.68% | ― |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| RSLBF | RaySearch Laboratories AB | 20.00 | -3.59 | -15.20% |
| Name | Price | % Change | |
|---|---|---|---|
| RSLBF | $20.00 | -15.20% |
An announcement from RaySearch Laboratories AB ( ($SE:RAY.B) ) is now available. Leeds Cancer Centre has treated its first patient using RayStation v2026’s new reirradiation functionality, making it the first
The latest update is out from RaySearch Laboratories AB ( ($SE:RAY.B) ). RaySearch Laboratories develops radiation-oncology software, including RayStation and RayCare, with a global focus on adaptive and proton therapy.
RaySearch Laboratories AB Class B (RSLBF) is scheduled to report 3rd quarter earnings on 11/03/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect RaySearch Laboratories AB Class
RaySearch Laboratories AB ( ($SE:RAY.B) ) has issued an update. RaySearch Laboratories AB is a Stockholm-based medical technology company specializing in innovative software for cancer treatment. Its core products include
RaySearch Laboratories AB ( ($SE:RAY.B) ) has shared an announcement. RaySearch Laboratories AB, a Swedish medtech firm focused on oncology software, develops systems that support treatment planning, clinical workflow, analytics,
An update from RaySearch Laboratories AB ( ($SE:RAY.B) ) is now available. RaySearch Laboratories, a Stockholm-based medical technology firm focused on oncology software such as RayStation and RayCare, is broadening
RaySearch Laboratories AB ( ($SE:RAY.B) ) has provided an announcement. RaySearch Laboratories AB has achieved a new clinical milestone with the go-live of its RayCare oncology information system and RayStation
An update from RaySearch Laboratories AB ( ($SE:RAY.B) ) is now available. RaySearch Laboratories AB and U.S.-based Accuray Incorporated have signed a definitive agreement to expand their collaboration around online
RaySearch Laboratories AB Class B (($SE:RAY.B)) has held its Q2 earnings call. Read on for the main highlights of the call. RaySearch Laboratories’ latest earnings call painted a mixed picture,
RaySearch Laboratories AB ( ($SE:RAY.B) ) has provided an announcement. RaySearch Laboratories reported a mixed second quarter, with order intake rising 23 percent to SEK 296 million while net sales
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| RSLBF | Feb 10, 2027Before Open | $598.88M | $0.28 | $42.03M | 2.87 | 29.78 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
